Kevin T. Mellem, Ph.D. - Publications
Affiliations: | 2013 | Chemistry and Chemical Biology | Harvard University, Cambridge, MA, United States |
Area:
synthesis of natural productsYear | Citation | Score | |||
---|---|---|---|---|---|
2018 | Koltun ES, Aay N, Buckl A, Jogalekar AS, Kiss G, Marquez A, Mellem KT, Mordec K, Saldajeno-Concar M, Semko CM, Tibrewal N, Tzitzilonis C, Won W, Smith JA, Wilson SE, et al. Abstract 4878: RMC-4550, an allosteric inhibitor of SHP2: Synthesis, structure, and anti-tumor activity Cancer Research. 78: 4878-4878. DOI: 10.1158/1538-7445.Am2018-4878 | 0.301 | |||
2013 | Mellem KT, Myers AG. A simple, scalable synthetic route to (+)- and (-)-pseudoephenamine. Organic Letters. 15: 5594-7. PMID 24138164 DOI: 10.1021/Ol402815D | 0.528 | |||
2013 | Hugelshofer CL, Mellem KT, Myers AG. Synthesis of quaternary α-methyl α-amino acids by asymmetric alkylation of pseudoephenamine alaninamide pivaldimine. Organic Letters. 15: 3134-7. PMID 23746325 DOI: 10.1021/Ol401337P | 0.497 | |||
2012 | Morales MR, Mellem KT, Myers AG. Pseudoephenamine: a practical chiral auxiliary for asymmetric synthesis. Angewandte Chemie (International Ed. in English). 51: 4568-71. PMID 22461381 DOI: 10.1002/Anie.201200370 | 0.536 | |||
2012 | Morales MR, Mellem KT, Myers AG. ChemInform Abstract: Pseudoephenamine: A Practical Chiral Auxiliary for Asymmetric Synthesis. Cheminform. 43: no-no. DOI: 10.1002/chin.201238022 | 0.535 | |||
Show low-probability matches. |